Pegfilgrastim-gema Compared to Pegfilgrastim-roche for Prevention of Induced Neutropenia in Breast Cancer Patients.
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Peg-Filgrastim
Sponsor: Gema Biotech S.A.
Collaborators: QUID Quality in Drugs and Devices Latin American Consulting SRL